A pathophysiological interpretation of unresponsiveness to spironolactone in a stepped-care approach to the diuretic treatment of ascites in nonazotemic cirrhotic patientsAngelo Gatta, Carlo Merkel, Paolo Angeli et al.|Hepatology|1991Cited by 90
Tubular site of renal sodium retention in ascitic liver cirrhosis evaluated by lithium clearancePaolo Angeli, A. Ruol, Angelo Gatta et al.|European Journal of Clinical Investigation|1990Cited by 80
Nadolol for Prevention of Variceal Rebleeding in Cirrhosis: A Controlled Clinical TrialAngelo Gatta, A. Ruol, Carlo Merkel et al.|Digestion|2009Cited by 69
Prognostic indicators of survival in patients with cirrhosis and esophageal varices, without previous bleeding.Carlo Merkel, Angelo Gatta, Massimo Bolognesi et al.|PubMed|1989Cited by 62
Hepatic decompensation is the major driver of mortality in patients with HCC treated with atezolizumab plus bevacizumab: The impact of successful antiviral treatmentCiro Celsa, Johann von Felden, Peter R. Galle et al.|Hepatology|2024Cited by 52